Skip to content
Contact Us
About Us Cancer Glossary A—Z Find a Treatment Center Contact Get in Touch

Multiple Myeloma: Symptoms, Causes, Stages & Treatment

blood-cancers, Cancer Types AÔÇôZ

Multiple myeloma is a type of blood cancer that develops in plasma cells – white blood cells found in bone marrow that help the body fight infections. When plasma cells become cancerous, they multiply without control, build up in the bone marrow, and interfere with the production of healthy blood cells. Understanding multiple myeloma symptoms, causes, stages, and treatments can help patients and families navigate diagnosis and care with clarity and confidence.

Meta Description: Learn about multiple myeloma, including symptoms, causes, stages, diagnosis, treatment options, and living with the condition. Simple and medically accurate.

What is Multiple Myeloma?

Multiple myeloma is a cancer of bone marrow plasma cells. These cancerous cells produce abnormal proteins called monoclonal proteins (M proteins) that can damage bones, kidneys, and the immune system. Myeloma may develop slowly, causing few symptoms at first, or progress more quickly and require immediate medical care [1].

This cancer is more common in older adults and often occurs after age 60. While there is no known cure, many treatment options can manage symptoms, slow disease progression, and improve quality of life.

Symptoms & Warning Signs

Symptoms vary widely depending on how advanced the disease is and which organs are affected. Some people experience mild symptoms early on, while others notice more significant changes later. Because symptoms may resemble other health conditions, early myeloma is sometimes discovered through routine blood tests [2].

Common symptoms include:

  • Bone pain, especially in back, ribs, or hips
  • Fatigue or weakness due to anemia
  • Frequent infections or slow recovery from illnesses
  • High calcium levels causing thirst, confusion, or constipation
  • Kidney problems or changes in urine output
  • Unexplained weight loss
  • Numbness or tingling in limbs (nerve involvement)
  • Bruising or bleeding more easily

Some patients may not notice symptoms for months or even years. Others may develop sudden bone fractures with minor injury due to weakened bone structure.

Causes & Risk Factors

The exact cause of multiple myeloma remains unclear, but several risk factors may increase the likelihood of developing it. Having one or more risk factors does not guarantee disease development, but awareness can encourage early monitoring [3].

Potential risk factors include:

  • Older age (most cases occur over 60)
  • Male gender (slightly higher risk)
  • Family history of blood cancers
  • Obesity or reduced physical activity
  • Exposure to radiation or industrial chemicals
  • History of monoclonal gammopathy of undetermined significance (MGUS)

MGUS is a non-cancerous condition where abnormal plasma cells are present. A small percentage of MGUS patients may develop multiple myeloma over time.

Diagnosis & Tests

Diagnosing multiple myeloma involves identifying abnormal plasma cells, measuring monoclonal protein levels, and assessing organ involvement. Many people discover the condition through routine blood work before symptoms develop. A combination of laboratory tests and imaging helps doctors confirm diagnosis and determine how advanced the disease is [1].

Common diagnostic tests include:

  • Blood Tests: Check for M proteins, anemia, calcium levels, and kidney function.
  • Urine Tests: Look for Bence Jones proteins, an indicator of myeloma.
  • Bone Marrow Biopsy: Confirms presence of cancerous plasma cells.
  • Imaging Scans: X-ray, MRI, CT, or PET scans detect bone damage or lesions.
  • Electrophoresis Testing: Measures monoclonal protein levels in blood and urine.
  • Free Light Chain Assay: Helps monitor disease progression.

Diagnosing early allows doctors to begin treatment faster and reduce the risk of bone and kidney complications.

Stages of Multiple Myeloma

Staging helps determine how advanced the disease is and guides treatment decisions. The most common system used is the International Staging System (ISS), based on blood albumin and beta-2 microglobulin levels.

Stages include:

  • Stage I: Low levels of beta-2 microglobulin and normal albumin levels.
  • Stage II: Levels between Stage I and Stage III.
  • Stage III: Elevated beta-2 microglobulin, indicating more advanced disease.

Doctors may also assess:

  • Calcium levels
  • Bone damage or lesions
  • Kidney function
  • M protein concentration
  • Genetic markers indicating aggressiveness

Staging helps predict how the disease may progress and how well patients respond to treatment.

Treatment Options

Multiple myeloma treatment varies depending on stage, symptoms, and overall health. Some individuals with early-stage disease may not need treatment immediately and instead begin with “active surveillance.” When treatment is necessary, it usually aims to slow cancer growth, reduce symptoms, and improve quality of life [2].

Common treatment approaches:

  • Targeted Therapy: Drugs designed to attack cancer cell proteins.
  • Immunotherapy: Boosts the immune system to recognize and destroy cancer cells.
  • Chemotherapy: Kills fast-growing cancer cells, often used in combination.
  • Stem Cell Transplant: Replaces damaged bone marrow after high-dose treatment.
  • Radiation Therapy: Used to relieve bone pain or treat localized lesions.
  • Corticosteroids: Reduce inflammation and help destroy myeloma cells.

Treatment plans are often personalized. Many patients receive a combination of treatments during different phases of care.

Prognosis & Survival Outlook

The prognosis for multiple myeloma varies depending on age, stage, kidney function, and how well the cancer responds to treatment. Although there is no known cure, many people live for years with modern therapies, and some reach long-term remission [3].

Positive outcome factors may include:

  • Early detection and treatment
  • Younger age at diagnosis
  • Good kidney function
  • Responding well to first treatment
  • No high-risk gene mutations

Research continues to improve treatment strategies, leading to better survival rates than in previous decades. Some individuals receive maintenance therapy to keep the cancer controlled after remission.

Prevention & Lifestyle Support

There is no proven method to prevent multiple myeloma. However, healthy habits may support the immune system and reduce risk of complications during treatment. These steps can help the body stay strong and manage treatment side effects.

Helpful lifestyle practices:

  • Stay physically active with light exercise (as advised by a doctor)
  • Eat a balanced diet rich in fruits, vegetables, and whole foods
  • Drink plenty of water to support kidney health
  • Limit alcohol and avoid smoking
  • Get regular medical checkups
  • Practice stress management and emotional support activities

Working with a dietitian or cancer care team can help create a nutrition plan tailored to individual energy needs.

Living with Multiple Myeloma

Living with myeloma can affect daily life physically and emotionally. Many people benefit from learning about treatment options, side effects, and support resources. Emotional support is especially important for long-term management.

Tips for coping with myeloma:

  • Discuss fatigue, bone pain, or new symptoms with doctors
  • Protect bones by avoiding heavy lifting without guidance
  • Join support groups for shared experience and encouragement
  • Track treatment effects and lab results in a journal
  • Seek counseling or mental health support if feeling overwhelmed
  • Get enough rest and maintain a sleep routine

Caregivers also play a major role in providing support, helping manage medications, and offering companionship during treatment.

FAQ — Understanding Multiple Myeloma Better

Q: Is multiple myeloma curable?

A: There is no confirmed cure yet, but many people live long lives with treatment. Remission is possible, and long-term disease control has improved with new therapies.

Q: What is the first sign of multiple myeloma?

A: Bone pain and fatigue are common early signs, but symptoms vary. Some cases are discovered during routine blood tests.

Q: Can multiple myeloma return after treatment?

A: Relapse can occur. Doctors may adjust or combine treatments to manage recurrence.

Q: Does multiple myeloma run in families?

A: A small portion may have genetic influence, but most cases develop without family history.

Q: Can diet help treat myeloma?

A: Diet supports strength and recovery but does not replace medical treatment. A healthcare team can guide nutrition choices.

Q: What organs can be affected by multiple myeloma?

A: Myeloma can affect bones, kidneys, immune system function, and sometimes nerves. Monitoring organ health is an important part of treatment care.

Q: How long can someone live with multiple myeloma?

A: Life expectancy varies widely. Some people live many years with treatment and follow-up care. Early response to treatment often improves long-term outcomes.

Q: What is MGUS and how is it related?

A: MGUS (Monoclonal Gammopathy of Undetermined Significance) is a non-cancerous condition with abnormal plasma cells. A small percentage may develop myeloma over time, so monitoring is recommended.

References


Disclaimer: This information is for educational purposes only and is not medical advice. Talk to a healthcare provider about questions related to your health.

Share this article:

Related Posts